Joshua A Beckman
Vanderbilt University Medical Center · Brigham and Women's Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Joshua A Beckman as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:39 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT02975583 · Vorapaxar and Lower Extremity Bypass GraftsVanderbilt University · withdrawn · Peripheral Artery Disease · principal investigator
- N/ANCT00762242 · Metabolomic Profiling of Novel Mediators of Vascular FunctionBrigham and Women's Hospital · terminated · Type 2 Diabetes Mellitus · principal investigator
- Ph2/Ph3NCT00760019 · Inflammation and Vascular Function in AtherosclerosisBrigham and Women's Hospital · completed · Atherosclerosis · principal investigator
- N/ANCT00759707 · Endothelial Function in Lower Extremity Bypass GraftsBrigham and Women's Hospital · completed · Peripheral Arterial Disease · principal investigator
- Ph2/Ph3NCT00759291 · The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic SyndromeBrigham and Women's Hospital · completed · Metabolic Syndrome · principal investigator
- Ph2/Ph3NCT00759525 · The Role of Mineralocorticoid Receptors in Vascular FunctionBrigham and Women's Hospital · completed · Apparent Mineralocorticoid Excess (AME) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 5 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- The Impact of Diabetes on Revascularization in BEST-CLIR01HL131977 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2016 to 2020 · $787,467 awarded in 2020Same name and institution; not confirmed by an ID
- Training in Cardiovascular ResearchT32HL007411 · NHLBI · VANDERBILT UNIVERSITY · fiscal years 2019 to 2020 · $175,755 awarded in 2020Same name and institution; not confirmed by an ID
- A pilot study of moderate hyperbilirubinemia in type 1 diabetes mellitusR03DK094510 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2011 · $89,229 awarded in 2011Same name and institution; not confirmed by an ID
- THE ROLE OF MINERALOCORTICOID RECEPTORS IN VASCULAR FUNCTIONM01RR002635 · NCRR · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2004 to 2005 · $2,233 awarded in 2005Same name and institution; not confirmed by an ID
- MECHANISMS OF ENDOTHELIAL DYSFUNCTION IN DIABETICSK23HL004169 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 1999 to 2003 · $124,200 awarded in 2003Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:39 UTC. The ranking covers the 200 most relevant of 29 PubMed records, and a shared surname and initials can bring in a namesake. All 29 on PubMed
- Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans.Circulation · 2001241 citationsRCR 6.3
- Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans.Circ Res · 2002226 citationsRCR 5.1
- Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia.J Vasc Surg · 2008124 citationsRCR 3.7
- Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.Circ Res · 2004107 citationsRCR 2.8
- Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus.Am J Physiol Heart Circ Physiol · 2003102 citationsRCR 2.6
- Contrary effects of the receptor tyrosine kinase inhibitor vandetanib on constitutive and flow-stimulated nitric oxide elaboration in humans.Hypertension · 201145 citationsRCR 1.1
- Enoxaparin monotherapy without oral anticoagulation to treat acute symptomatic pulmonary embolism.Thromb Haemost · 200343 citationsRCR 1.1
- Metabolic Effects of Betaine: A Randomized Clinical Trial of Betaine Supplementation in Prediabetes.J Clin Endocrinol Metab · 201842 citationsRCR 2.1
- Comparative effects of weight loss and incretin-based therapies on vascular endothelial function, fibrinolysis and inflammation in individuals with obesity and prediabetes: A randomized controlled trial.Diabetes Obes Metab · 202333 citationsRCR 3.7
- Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization: Insights From VOYAGER PAD.Circulation · 202132 citationsRCR 2.1